It interpret SLOGGER differently to you, but thats OK, who cares.
Lets cover the developed products
Axiron - good money spinner probably last for quite a while.
I would not count Lenzetto as being in the pipeline as I interpret "the pipeline" to be products in development- Lenzetto is developed. Even in the companies own opinion its not going to a big money spinner like Axiron, at least any time soon. It might produce a few percent of the Axiron sales sometime soon, maybe.
They also have Recuvyra - seems dead to me.
Now Products in Development - "the pipeline"
Since nothing has come out of this "development pipeline" for some time, my issue is how do we know anything will come out of it ever again?
You seem to believe it will, you have faith. Where does this come from? What have they said to convince you, given money has gone in for years and nothing out? That's what my question is. I have read their presentations and it seems to me its nothing more than a fantasy made up try to stave off angry shareholders who want results. I mean they are probably doing something - but just not getting far. What makes you think they are?
ACR Price at posting:
64.5¢ Sentiment: Hold Disclosure: Held
